Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

pembrolizumab 31 Injections 26 Interviews as Topic 16 Pemetrexed 15 tislelizumab 13 Specimen Handling 13 Carboplatin 13 Cisplatin 12 Nivolumab 11 atezolizumab 10 Practice Guidelines as Topic 9 Educational Status 9 Cyclophosphamide 9 Bevacizumab 9 Standard of Care 8 Oxaliplatin 8 Fluorouracil 8 fludarabine 7 Methods 7 Early Intervention, Educational 7 Docetaxel 7 Cetuximab 7 Capecitabine 7 toripalimab 6 sotorasib 6 Platinum 6 Paclitaxel 6 Leucovorin 6 Ipilimumab 6 Gemcitabine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Off-Label Use × Other solid neoplasm × 90 days × Clear all

NCT06956248 2026-05-13

IMPACT-INSPIRE

National Cancer Centre, Singapore

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡